TAMPA, Florida – TruPharma, LLC (TruPharma) announced today that it has launched an authorized generic Clonidine Transdermal System that is a multi-layered film in three presentations, programed to deliver 0.1 mg/day, 0.2 mg/day, and 0.3 mg/day. The FDA-approved product is being supplied to TruPharma pursuant to an agreement with Technomed, Inc. and is an authorized generic version of the Catapres-TTS® branded product.